Gastroenterologie Leber Neoplasie

En | De
Sie sind hier: Gastroenterologie » Leber » Neoplasie 01. April 2023
Erweiterte Suche
Portale Hypertonie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 3220  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 64399  
Above-Standard Survival of Hepatocellular Carcinoma as the Final Outcome of Comprehensive Hepatology Care Programs in a Remote HCV-Endemic Area.
Cho WR, Huang HL, Hsu NT, Huang TJ, Chang TS.
PMID: 36992494 [PubMed - indexed for MEDLINE]

The role of N-glycosylation modification in the pathogenesis of liver cancer.
Cell Death Dis
Hu M, Zhang R, Yang J, Zhao C, Liu W, Huang Y, Lyu H, Xiao S, Guo D, Zhou C, Tang J.
PMID: 36990999 [PubMed - indexed for MEDLINE]

The Role of Stereotactic Body Radiation Therapy in the Management of Liver Metastases.
Semin Radiat Oncol
Lee SL, Bassetti MF, Rusthoven CG.
PMID: 36990635 [PubMed - indexed for MEDLINE]

Microwave ablation as a primary versus secondary treatment for hepatocellular carcinoma.
Diagn Interv Radiol
Lee P, Makkena A, Tantawi M, Velasquez-Botero F, Eisenbrey JR, Shaw CM.
PMID: 36988024 [PubMed - indexed for MEDLINE]

Long-term outcomes of combined radiofrequency ablation and multipronged ethanol ablation for the treatment of unfavorable hepatocellular carcinoma.
Diagn Interv Radiol
Liu M, Li XJ, Zhang XE, Kuang M, Xie XY, Huang GL.
PMID: 36987999 [PubMed - indexed for MEDLINE]

Vascular complications related to image-guided percutaneous thermal ablation of hepatic tumors.
Diagn Interv Radiol
Tashi S, Gogna A, Leong S, Venkatanarasimha N, Chandramohan S.
PMID: 36987983 [PubMed - indexed for MEDLINE]

Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?
Gudan A, Koz, Wunsch E, Bodnarczuk T, Stachowska E.
PMID: 36986052 [PubMed - indexed for MEDLINE]

Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after Successful Treatment with Direct-Acting Antivirals.
Medicina (Kaunas)
Rodprasert N, Hongboontry T, Cherdchoochart C, Chaiteerakij R.
PMID: 36984603 [PubMed - indexed for MEDLINE]

New Insights in the Setting of Transplant Oncology.
Medicina (Kaunas)
Quaresima S, Melandro F, Giovanardi F, Shah K, De Peppo V, Mennini G, Ghinolfi D, Limkemann A, Pawlik TM, Lai Q.
PMID: 36984569 [PubMed - indexed for MEDLINE]

Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer.
Huang PS, Wang LY, Wang YW, Tsai MM, Lin TK, Liao CJ, Yeh CT, Lin KH.
PMID: 36980210 [PubMed - indexed for MEDLINE]

Chemoembolization combined radiofrequency ablation vs. chemoembolization alone for treatment of beyond the Milan criteria viable hepatocellular carcinoma (CERFA): study protocol for a randomized controlled trial.
Lee SK, Yang H, Kwon JH, Shim DJ, Kim D, Nam SW, Yoo SH, Bae SH, Lee A, Lee YJ, Jeon C, Jang JW, Sung PS, Chun HJ, Kim SH, Choi JI, Oh JS, Yang YJ.
PMID: 36978150 [PubMed - indexed for MEDLINE]

Identification of biomarkers of hepatocellular carcinoma gene prognosis based on the immune-related lncRNA signature of transcriptome data.
Funct Integr Genomics
Ma A, Sun Y, Ogbodu RO, Xiao L, Deng H, Zhou H.
PMID: 36976410 [PubMed - indexed for MEDLINE]

Alcoholic Liver Disease-Related Hepatocellular Carcinoma: Characteristics and Comparison to General Slovak Hepatocellular Cancer Population.
Curr Oncol
, Dra, Gazda J, Andra, Adamcová-Sel, Barila R, Mego M, Rác M, Skladaný , , Jani, Jar.
PMID: 36975484 [PubMed - indexed for MEDLINE]

CXCL1 and CXCL6 Are Potential Predictors for HCC Response to TACE.
Curr Oncol
Kinzler MN, Bankov K, Bein J, Döring C, Schulze F, Reis H, Mahmoudi S, Koch V, Grünewald LD, Stehle A, Walter D, Finkelmeier F, Zeuzem S, Wild PJ, Vogl TJ, Bernatz S.
PMID: 36975480 [PubMed - indexed for MEDLINE]

Optimizing Growth of the Future Liver Remnant and Making In-Situ Liver Transsection Safe-A Standardized Approach to ISLT or ALPPS.
Curr Oncol
Alexander A, Lehwald-Tywuschik N, Rehders A, Dizdar L, Fluegen G, Safi SA, Knoefel WT.
PMID: 36975462 [PubMed - indexed for MEDLINE]

Survival Benefit of Experience of Liver Resection for Advanced Recurrent Hepatocellular Carcinoma Treated with Sorafenib: A Propensity Score Matching Analysis.
Curr Oncol
Hsueh KC, Lee CC, Huang PT, Liang CY, Yang SF.
PMID: 36975456 [PubMed - indexed for MEDLINE]

Prognostic Impact of a Novel Albumin-Platelet Index as Selection Criterion for Hepatic Resection in Intermediate Stage Hepatocellular Carcinoma.
Anticancer Res
Yugawa K, Maeda T, Nagata S, Sakai A, Taketani K, Yamaguchi S, Konishi K, Hashimoto K.
PMID: 36974828 [PubMed - indexed for MEDLINE]

A Multidisciplinary Treatment Strategy With Conversion Surgery for Hepatocellular Carcinoma.
Anticancer Res
Shiozaki H, Furukawa K, Haruki K, Matsumoto M, Uwagawa T, Onda S, Yamahata Y, Ishizaki S, Abe K, Fujioka S, Nakaseko Y, Okamoto T, Ikegami T.
PMID: 36974796 [PubMed - indexed for MEDLINE]

The Japanese 5-5-500 Rule Predicts Prognosis of Hepatocellular Carcinoma After Hepatic Resection.
Anticancer Res
Takishima T, Haruki K, Taniai T, Furukawa K, Horiuchi T, Onda S, Yanagaki M, Shirai Y, Hamura R, Ikegami T.
PMID: 36974785 [PubMed - indexed for MEDLINE]

Identification of Atezolizumab Plus Bevacizumab Prognostic Index via Recursive Partitioning Analysis in HCC: The ABE Index.
Anticancer Res
Persano M, Rimini M, Tada T, Suda G, Shimose S, Kudo M, Cheon J, Finkelmeier F, Lim HY, Presa J, Masi G, Yoo C, Lonardi S, Pressiani T, Piscaglia F, Kumada T, Rimassa L, Scartozzi M, Cascinu S, Casadei-Gardini A, HCC COLLABORATIVE GROUP.
PMID: 36974779 [PubMed - indexed for MEDLINE]

   Artikel 1 - 20 / 64399    Seite 1 von 3220  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer





Haben Sie Ihr Passwort vergessen?


Neu bei My Medline?

Melden Sie sich bei My Medline an!


Mehr über My Medline erfahren

mehr >>


Benutzen Sie englische Suchbegriffe für Ihre Suche in



mehr >>


Sky right 1